What Should Be Considered in Treatment of Melasma
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Melasma is a common acquired hyperpigmentary skin disorder characterized by light to dark brown macules and patches occurring in the sun-exposed areas of the face. Melasma lesional skin is characterized by epidermal hyperpigmentation through increased melanogenesis in epidermal melanocytes. Some patients have dermal melanin but its amount is not significant and its distribution is very heterogeneous in the whole melasma lesional skin. Melasma is not homogeneous disease and there are personal characteristics of patients with melasma. The pathogenesis of melasma is not fully understood, but several hypotheses have been suggested. Increased vascularity in melasma lesions has suggested the role of increased number of enlarged vessels in the development of melasma. Endogeneous and exogeneous stimuli such as sex hormones and ultraviolet irradiation respectively may stimulate the microenvironment leading to the release of various mediators that cause activation of melanocytes and/or these stimuli may directly activate the melanocytes. Melasma patients may have specialized melanocytes with an intrinsic sensitivity to these stimuli. (Ann Dermatol 22(4) 373∼378, 2010)
Abstract
Melasma is a common acquired hyperpigmentary skin disorder characterized by light to dark brown macules and patches occurring in the sun-exposed areas of the face. Melasma lesional skin is characterized by epidermal hyperpigmentation through increased melanogenesis in epidermal melanocytes. Some patients have dermal melanin but its amount is not significant and its distribution is very heterogeneous in the whole melasma lesional skin. Melasma is not homogeneous disease and there are personal characteristics of patients with melasma. The pathogenesis of melasma is not fully understood, but several hypotheses have been suggested. Increased vascularity in melasma lesions has suggested the role of increased number of enlarged vessels in the development of melasma. Endogeneous and exogeneous stimuli such as sex hormones and ultraviolet irradiation respectively may stimulate the microenvironment leading to the release of various mediators that cause activation of melanocytes and/or these stimuli may directly activate the melanocytes. Melasma patients may have specialized melanocytes with an intrinsic sensitivity to these stimuli. (Ann Dermatol 22(4) 373∼378, 2010)
참고문헌 (35)
- Ortonne JP, "A global survey of the role of ultraviolet radiation and hormonal influences in the development of melasma", J Eur Acad Dermatol Venereol, 23, pp.1254~1262 (2009)
- Kang HY, "The role of topical retinoids in the treatment of pigmentary disorders:an evidence-based review", Am J Clin Dermatol, 10, pp.251~260 (2009)
- Ortonne JP, "Melanin pigmentary disorders:treatment update", Dermatol Clin, 23, pp.209~226 (2005)
- Negishi K, "Study of the incidence and nature of"very subtle epidermal melasma"in relation to intense pulsed light treatment", Dermatol Surg, 30, pp.881~886 (2004)
- Lee HS, "Treatment of melasma in Asian skin using a fractional 1,550-nm laser:an open clinical study", Dermatol Surg, 35, pp.1499~1504 (2009)
- 정세영, "Collimated Low Fluence Q-switched Nd：YAG 레이저를 이용한 새로운 기미 치료법", 대한피부과학회지, 46(9), pp.1163~1170 (2008), 대한피부과학회
- Polnikorn N, "Treatment of refractory dermal melasma with the MedLite C6 Q-switched Nd:YAG laser:two case reports", J Cosmet Laser Ther, 10, pp.167~173 (2008)
- Cho SB, "Melasma treatment in Korean women using a 1064-nm Q-switched Nd:YAG laser with low pulse energy", Clin Exp Dermatol, 34, pp.e847~e850 (2009)
- Kim MJ, "Punctate leucoderma after melasma treatment using 1064-nm Q-switched Nd:YAG laser with low pulse energy", J Eur Acad Dermatol Venereol, 23, pp.960~962 (2009)
- Sanchez NP, "Melasma:a clinical,light microscopic,ultrastructural,and immunofluorescence study", J Am Acad Dermatol, 4, pp.698~710 (1981)
- Grimes PE, "Light microscopic,immunohistochemical,and ultrastructural alterations in patients with melasma", Am J Dermatopathol, 27, pp.96~101 (2005)
- Sarvjot V, "Melasma:a clinicopathological study of 43 cases", Indian J Pathol Microbiol, 52, pp.357~359 (2009)
- Lawrence N, "Treatment of melasma with Jessner's solution versus glycolic acid:a comparison of clinical efficacy and evaluation of the predictive ability of Wood's light examination", J Am Acad Dermatol, 36, pp.589~593 (1997)
- Kang HY, "In vivo reflectance confocal microscopy detects pigmentary changes in melasma at a cellular level resolution", Exp Dermatol, 19, pp.e228~e233 (2010)
- Kang WH, "Melasma:histopathological characteristics in 56 Korean patients", Br J Dermatol, 146, pp.228~237 (2002)
- Moncada B, "Molecular structure and concentration of melanin in the stratum corneum of patients with melasma", Photodermatol Photoimmunol Photomed, 25, pp.159~160 (2009)
- Kim EH, "The vascular characteristics of melasma", J Dermatol Sci, 46, pp.111~116 (2007)
- Kim EJ, "Modulation of vascular endothelial growth factor receptors in melanocytes", Exp Dermatol, 14, pp.625~633 (2005)
- Jo HY, "Co-localization of inducible nitric oxide synthase and phosphorylated Akt in the lesional skins of patients with melasma", J Dermatol, 36, pp.10~16 (2009)
- Mahmoud BH, "Impact of long-wavelength UVA and visible light on melanocompetent skin", J Invest Dermatol, 130, pp.2092~2097 (2010)
- Hernández-Barrera R, "Solar elastosis and presence of mast cells as key features in the pathogenesis of melasma", Clin Exp Dermatol, 33, pp.305~308 (2008)
- Suzuki I, "Increase of pro-opiomelanocortin mRNA prior to tyrosinase,tyrosinase-related protein 1,dopachrome tauto merase,Pmel-17", gp100,and P-protein mRNA in human skin after ultraviolet B irradiation, 2002, pp.118, 73~78
- Im S, "Increased expression of alpha-melanocyte-stimulating hormone in the lesional skin of melasma", Br J Dermatol, 146, pp.165~167 (2002)
- Kang HY, "The dermal stem cell factor and c-kit are overexpressed in melasma", Br J Dermatol, 154, pp.1094~1099 (2006)
- Imokawa G, "Autocrine and paracrine regulation of melanocytes in human skin and in pigmentary disorders", Pigment Cell Res, 17, pp.96~110 (2004)
- Rhodes LE, "The sunburn response in human skin is characterized by sequential eicosanoid profiles that may mediate its early and late phases", FASEB J, 23, pp.3947~3956 (2009)
- Kapoor R, "Evaluation of safety and efficacy of topical prostaglandin E2 in treatment of vitiligo", Br J Dermatol, 160, pp.861~863 (2009)
- Hexsel D, "Melasma and pregnancy in southern Brazil", J Eur Acad Dermatol Venereol, 23, pp.367~368 (2009)
- Moin A, "Prevalence and awareness of melasma during pregnancy", Int J Dermatol, 45, pp.285~288 (2006)
- Pérez M, "Endocrinologic profile of patients with idiopathic melasma", J Invest Dermatol, 81, pp.543~545 (1983)
- Jee SH, "Effects of estrogen and estrogen receptor in normal human melanocytes", Biochem Biophys Res Commun, 199, pp.1407~1412 (1994)
- Kippenberger S, "Quantification of tyrosinase,TRP-1,and Trp-2 transcripts in human melanocytes by reverse transcriptase-competitive multiplex PCR--regulation by steroid hormones", J Invest Dermatol, 110, pp.364~367 (1998)
- Lieberman R, "Estrogen receptor expression in melasma:results from facial skin of affected patients", J Drugs Dermatol, 7, pp.463~465 (2008)
- Jang YH, "Oestrogen and progesterone receptor expression in melasma: an immunohistochemical analysis", J Eur Acad Dermatol Venereol, ~ (2010)
- Kim NH, "H19 RNA downregulation stimulated melanogenesis in melasma", Pigment Cell Melanoma Res, 23, pp.84~92 (2010)